The remedial structure of the Act falls short of addressing circumstances where the IC itself fails to perform its duties by not rendering a recommendation.

The DeepSeek PIL is emblematic of a pivotal moment in the ongoing evolution of technology law.

The inclusion of blockchain into inheritance planning represents a paradigm shift with regards to an amalgamation of law and technology.

[ Himanshi is a student at Dharmashastra National Law University. ] The Committee on Digital Competition Law released the   draft Digital...

There is lack of clarity on data transfer that comes with proposed draft rules and it requires thorough consultation before implementation.

The author discusses the Banking Laws (Amendment) Bill 2024 and analyses its impact on the banking operations in the country.

Authors discuss the validity of e-notarization in India, focusing on the current stance taken by courts.

As India starts to ramp up strategies in the tech v/s media battlefield, it must create an approach that facilitates quality journalism.

With upscaling of cryptocurrency, the thin line between respecting one's privacy and breaching it willingly or unwillingly will vanish.

The successful implementation of NFIR policy is fundamental since it has potential to improve India’s credit landscape.

Per the author, leaving a whole segment of finfluencers unchecked leaves the consumer vulnerable.

The jurisprudence with regard to anti-competitive practices and IPR is still at a very nascent stage.

The authors of this article have argued that clarificatory amendments do not deserve the sharp criticism that they receive.

This article examines Energy Conservation (Amendment) Act 2022, notably Carbon Credit Trading Scheme, within the concerns of greenwashing.

Per the author, it is useful to examine the cost of pursuing green goals, given the existing housing demand in India.

Author analyses the provisions regarding cross-border transfer of data in the draft Digital Personal Data Protection Bill 2022.

Per the author, the ‘Heal In India’ initiative may have several pros and wins, but being alert to the cons is even more potent.

The Drugs & Cosmetics Bill gets it right on regulation of medical devices but continues with drug inspection regime that lacks transparency.

It is time to prioritize our nation’s healthcare needs and move in the right direction for ‘Heal in India’ first and then ‘Heal by India’.